Blue Trust Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Buy |
1,517
+79
| +5% | +$19.1K | ﹤0.01% | 562 |
|
|
2025
Q1 | $350K | Buy |
1,438
+374
| +35% | +$91.1K | ﹤0.01% | 520 |
|
|
2024
Q4 | $350K | Buy |
1,064
+8
| +0.8% | +$2.63K | ﹤0.01% | 483 |
|
|
2024
Q3 | $288K | Buy |
1,056
+197
| +23% | +$53.8K | ﹤0.01% | 696 |
|
|
2024
Q2 | $297K | Buy |
859
+143
| +20% | +$49.5K | ﹤0.01% | 559 |
|
|
2024
Q1 | $248K | Buy |
716
+236
| +49% | +$81.6K | ﹤0.01% | 441 |
|
|
2023
Q4 | $172K | Buy |
480
+142
| +42% | +$50.9K | ﹤0.01% | 494 |
|
|
2023
Q3 | $128K | Buy |
338
+239
| +241% | +$90.5K | ﹤0.01% | 551 |
|
|
2023
Q2 | $47K | Sell |
99
-569
| -85% | -$270K | ﹤0.01% | 711 |
|
|
2023
Q1 | $281K | Buy |
668
+158
| +31% | +$66.5K | ﹤0.01% | 428 |
|
|
2022
Q4 | $213K | Buy |
510
+278
| +120% | +$116K | ﹤0.01% | 430 |
|
|
2022
Q3 | $115K | Buy |
232
+49
| +27% | +$24.3K | ﹤0.01% | 481 |
|
|
2022
Q2 | $103K | Buy |
+183
| New | +$103K | ﹤0.01% | 484 |
|